AKTIONÄR-Top-Tipp Regeneron: Bockstarke Zahlen – magische Marke geknackt DER AKTIONÄR - 02 Feb 2024 AKTIONÄR-Top-Tipp Regeneron: Bockstarke Zahlen – magische Marke geknackt ... More
Regeneron: Wichtiger Erfolg – Aktie auf Rekordjagd - DER AKTIONÄR DER AKTIONÄR - 28 Dec 2023 Regeneron: Wichtiger Erfolg – Aktie auf Rekordjagd - DER AKTIONÄR ... More
VIRICA Index gibt Vollgas: Regeneron, Amgen und Vertex auf Rekordhoch DER AKTIONÄR - 04 Jan 2024 VIRICA Index gibt Vollgas: Regeneron, Amgen und Vertex auf Rekordhoch ... More
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth Reuters - 25 Apr 2024 Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth ... More
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration Genetic Engineering & Biotechnology News - 25 Apr 2024 Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration ... More
Sales of Roche's juggernaut Vabysmo rout the analyst consensus Fierce Pharma - 24 Apr 2024 Sales of Roche's juggernaut Vabysmo rout the analyst consensus ... More
Regeneron signs Mammoth gene editing deal worth $100M upfront Fierce Biotech - 25 Apr 2024 Regeneron signs Mammoth gene editing deal worth $100M upfront ... More
Regeneron and Mammoth announce gene editing partnership worth $370m per target PMLiVE - 26 Apr 2024 Regeneron and Mammoth announce gene editing partnership worth $370m per target ... More
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks Yahoo Finance - 24 Apr 2024 Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks ... More
Regeneron and Mammoth Biosciences to Collaborate European Pharmaceutical Manufacturer - 26 Apr 2024 Regeneron and Mammoth Biosciences to Collaborate ... More
Regeneron and Mammoth team up to develop gene editing therapies Pharmaceutical Technology - 26 Apr 2024 Regeneron and Mammoth team up to develop gene editing therapies ... More
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors MarketWatch - 26 Apr 2024 Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors ... More
Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines MedCity News - 25 Apr 2024 Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines ... More
Regeneron inks $100M deal to develop gene-editing therapies Crain's New York Business - 26 Apr 2024 Regeneron inks $100M deal to develop gene-editing therapies ... More
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery BioSpace - 25 Apr 2024 Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery ... More
AKTIONÄR-Top-Tipp Regeneron schlägt zu: Übernahme – Aktie schießt über 80 Prozent hoch DER AKTIONÄR - 10 Aug 2023 AKTIONÄR-Top-Tipp Regeneron schlägt zu: Übernahme – Aktie schießt über 80 Prozent hoch ... More
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent Fierce Pharma - 26 Apr 2024 Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent ... More
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study Reuters - 25 Apr 2024 AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study ... More
Regeneron to defend against DOJ complaint on drug-price manipulation Reuters - 15 Apr 2024 Regeneron to defend against DOJ complaint on drug-price manipulation ... More